Public Calendar: February 12-18, 2023

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 02/13/2023
Location: Washington, DC
Subject: Biopharma Congress
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, academia, industry, media, and other registered participants

Event Date: 02/13/2023
Location: Washington, DC
Subject: Trusted Exchange Framework and Common Agreement
FDA Participant/Group: N/A
Non FDA Participant/Group: Several government leaders and participants from Qualified Health Information Networks

Event Date: 02/14/2023
Location: Virtual
Subject: Human Foods Program
FDA Participant/Group: JANET WOODCOCK; JULIA TIERNEY; COURTNEY BUCHANAN; MELISSA SAFFORD; TRISTAN COLONIUS;
Non FDA Participant/Group: Roberta Wagner (Consumer Brands Association); De Ann Davis (Western Growers); Brian Ronholm (Consumer Reports); Jennifer McEntire (International Fresh Produce Association); Donna Garren (American Frozen Food Institute); Mitzi Baum (STOP Foodborne Illness); Steve Mandernach (Association of Food and Drug Officials); Scott Faber (Environmental Working Group);

Event Date: 02/15/2023
Location: Virtual
Subject: Digital Medicine Society: Diversity, Equity and Inclusion in Digitized Clinical Trials
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, academia, industry, and other registered guests

Event Date: 02/15/2023
Location: Washington, DC
Subject: National Association of State Departments of Agriculture (NASDA) Winter Policy Conference
FDA Participant/Group: DOUGLAS STEARN; ERIK METTLER; COURTNEY BUCHANAN; CATHERINE MCDERMOTT;
Non FDA Participant/Group: Government and members of NASDA

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 02/14/2023
Location: Virtual
Subject: Patient-Centered Outcomes Research Institute (PCORI) Board of Governors
FDA Participant/Group: N/A
Non FDA Participant/Group: Participants consists of the Directors of the National Institutes of Health, the Agency for Healthcare Research and Quality or their designees, and up to 21 additional members representing a range of stakeholder audiences

Event Date: 02/14/2023
Location: Arlington, VA
Subject: National Association of State Departments of Agriculture (NASDA) Winter Policy Conference; Opening Remarks
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government and members of NASDA

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 02/15/2023
Location: Virtual
Subject: Research!America Alliance Guest Speaker Webinar
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, academia, and other stakeholders

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 02/15/2023
Location: Virtual
Subject: Food Traceability Issues of Mutual Interest
FDA Participant/Group: JASMINE SMITH-DULLEY; JULIE MOSS; DONALD PRATER;
Non FDA Participant/Group: Several leaders and staff from the Australian Department of Agriculture, Fisheries, and Forestry

Event Date: 02/15/2023
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS; JASMINE SMITH-DULLEY;
Non FDA Participant/Group: Gillian Kelleher (Kelleher Consultants); Brian Olney, Dave Corsi, Kathleen O’Donnell, Martha Hilton, Steve Aloi (Wegman's);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

Event Date: 02/14/2023
Location: Arlington, VA
Subject: National Association of State Departments of Agriculture (NASDA) Winter Policy Conference
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government and members of NASDA

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 02/13/2023
Location: Virtual
Subject: Waived Total Protein Tests
FDA Participant/Group: TIMOTHY STENZEL; TAMARA PINKNEY; NICOLE VERDUN; RYAN LUBERT; ANNE EDER;
Non FDA Participant/Group: Alice Akinsulie, Tom Lilburn, Dominika Misztela and Bill Speir (Plasma Protein Therapeutics Association); Michele Battle (Octapharma Plasma); Mark Becker (Grifols); Roger Brinser (Takeda); Jennifer Duven (BPL); David Evans (Kelley Drye & Warren); Karina Lynch (Williams & Jensen)

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 02/14/2023
Location: Washington, DC
Subject: National Association of State Departments of Agriculture (NASDA) Winter Policy Conference
FDA Participant/Group: MARK MOORMAN; CAROL CAVE; TRACEY FORFA; CATHERINE MCDERMOTT; DOUGLAS STEARN; JEFFREY FARRAR; ERIK METTLER; BARBARA CASSENS; FRANK YIANNAS; JAMES GORNY; STEVEN MUSSER; JUDITH MCMEEKIN; MICHAEL ROGERS; PAUL NORRIS;
Non FDA Participant/Group: Government and members of NASDA

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Acting Director, Center for Veterinary Medicine

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event